2023-01-30 ASH Highlights: Monoclonal/Bispecific Antibodies, Complement Cascade
2023-01-30 ASH Highlights: Monoclonal/Bispecific Antibodies, Complement Cascade Read More »
In this Deep Dive Session, Prof. Mohamad Mohty discusses the latest advancements in the treatment of multiple myeloma, including the use of novel therapies and the importance of genetic testing
2022-10-17 Approaches to Management of Refractory-Relapsed Multiple Myeloma Read More »
In this Deep Dive Session, Prof. Laurie Sehn, a haematologist based at the British Colombia Cancer Center for Lymphoid Cancer, provides a comprehensive overview of the current landscape of Diffuse
2022-10-10 The Evolving Treatment Landscape in DLBCL Read More »
In this Deep Dive Session, Dr. Romana Jassat and Dr. Garrick Laudin present a comprehensive overview of Gray Zone Lymphoma, a rare and challenging disease entity that straddles the characteristics
2022-08-22 Grey Zone Lymphoma Read More »
In this Deep Dive Session, Prof. Pier Luigi Zinzani, from the University of Bologna, discusses the use of PD-1 inhibitors in the treatment of relapsed or refractory Hodgkin’s lymphoma. He
2022-05-27 Relapsed Refractory Hodgkin Lymphoma Management Read More »
In this Deep Dive Session, Dr. Johnny Mahlangu and Dr. Susan Louw discuss the evolution of hemophilia treatment, focusing on the transition from prophylaxis with factor replacement therapy to non-factor
2022-06-20 Haemophilia Treatment and Laboratory Diagnostics: A New Era Read More »
In this Deep Dive Session, Professor Arnon Kater from the University of Amsterdam provides an in-depth discussion on the treatment of chronic lymphocytic leukemia (CLL) with a focus on novel
2022-05-09 Approach to High-Risk CLL with Prof. Arnon Kater Read More »
In this Deep Dive Session, Dr. H Dewa and Dr Gugu Jali discuss various aspects of Myelodysplastic Syndromes (MDS), presenting several case studies and discussing their diagnosis and management. They
2022-04-25 Myelodysplastic Syndrome Led by UKZN Team Read More »
In this Deep Dive Session, Garrick Laudin, Nandipha Sigedle, and Jenifer Vaughan present on Acute Lymphoblastic Leukaemia (ALL). The discussion focuses on the genetic risk factors, particularly the translocation 1;19,
2022-02-28 Acute Lymphoblastic Leukaemia Read More »